Etonogestrel Implants Protect Ovarian Reserve Function in Systemic Lupus Erythematosus

PHASE2/PHASE3Not yet recruitingINTERVENTIONAL

Enrollment

180

Participants

Timeline

Start Date

April 1, 2023

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2025

Conditions

Systemic Lupus Erythematosus

Interventions

DRUG

Etonogestrel

Etongestrel implant will be implanted subcutaneously in the participant's non-dominant arm for one year

All Listed Sponsors

lead

Sixth Affiliated Hospital, Sun Yat-sen University

OTHER

NCT05791799 - Etonogestrel Implants Protect Ovarian Reserve Function in Systemic Lupus Erythematosus | Biotech Hunter | Biotech Hunter